This company listing is no longer active
CannAmerica Brands Past Earnings Performance
Past criteria checks 0/6
Key information
3.5%
Earnings growth rate
13.6%
EPS growth rate
| Pharmaceuticals Industry Growth | 23.1% |
| Revenue growth rate | -13.4% |
| Return on equity | n/a |
| Net Margin | -686.6% |
| Last Earnings Update | 30 Sep 2021 |
Recent past performance updates
Revenue & Expenses BreakdownBeta
How CannAmerica Brands makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 21 | 0 | -3 | 1 | 0 |
| 30 Jun 21 | 0 | -3 | 1 | 0 |
| 31 Mar 21 | 0 | -4 | 1 | 0 |
| 31 Dec 20 | 0 | -4 | 1 | 0 |
| 30 Sep 20 | 1 | -3 | 1 | 0 |
| 30 Jun 20 | 1 | -4 | 3 | 0 |
| 31 Mar 20 | 1 | -5 | 3 | 0 |
| 31 Dec 19 | 1 | -9 | 6 | 0 |
| 30 Sep 19 | 1 | -9 | 6 | 0 |
| 30 Jun 19 | 1 | -9 | 6 | 0 |
| 31 Mar 19 | 1 | -9 | 6 | 0 |
| 31 Mar 18 | 0 | 0 | 0 | 0 |
Quality Earnings: CANA is currently unprofitable.
Growing Profit Margin: CANA is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: Insufficient data to determine if CANA's year-on-year earnings growth rate was positive over the past 5 years.
Accelerating Growth: Unable to compare CANA's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: CANA is unprofitable, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (14.5%).
Return on Equity
High ROE: CANA's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.